Raytech Holding Ltd

Raytech Holding Limited announced strong financial results for fiscal year 2026, with revenue increasing by 81.1% to US$18.2 million and net income rising by 101.9% to US$2.1 million. The company successfully expanded its business model by adding two new service segments, which contributed 31.0% of total revenue. Key corporate developments included the acquisition of Worry free, a follow-on public offering, a share consolidation, and a subsequent registered direct offering to strengthen liquidity.

Raytech Holding Limited announced the closing of its registered direct offering on June 29, 2026, raising approximately $6.2 million in gross proceeds. The company issued 3,149,832 ordinary shares at a price of $1.97 per share. Raytech intends to utilize the net proceeds for general corporate and working capital needs, to fund its strategic expansion into the personal health care electronics sector, and to cover integration and working capital requirements related to the acquisition of Worry free Group (Hong Kong) Limited.

Raytech Holding Limited announced a strategic expansion into providing services for personal health care electronics, including product design, development, and consultations. This new direction, planned since Q3 FYE2026, will be led by its subsidiary, Raytech Innovation Limited. To spearhead this growth, the company appointed Mr. Haoyuan Liu as its new Chairman and Executive Director, effective April 15, 2026, leveraging his extensive experience in fintech and capital markets. Raytech aims to capitalize on the rapidly growing Asia Pacific wearable medical devices market, projected to reach US$26.83 billion by 2030, supported by its US$15.6 million cash reserves.